[go: up one dir, main page]

Craft et al., 2001 - Google Patents

Receptor-selective antagonism of opioid antinociception in female versus male rats

Craft et al., 2001

Document ID
939786340561162121
Author
Craft R
Tseng A
McNiel D
Furness M
Rice K
Publication year
Publication venue
Behavioural pharmacology

External Links

Snippet

This study was conducted to determine whether sex differences in opioid antinociception may be explained by sex differences in opioid receptor activation. The time course, dose– effect and selectivity of antagonists that have been previously shown to be relatively mu (β …
Continue reading at journals.lww.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication Publication Date Title
Craft et al. Receptor-selective antagonism of opioid antinociception in female versus male rats
Stratford et al. Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake
Cicero et al. Gender differences in the intravenous self-administration of mu opiate agonists
Mika et al. The role of δ-opioid receptor subtypes in neuropathic pain
Craft Sex differences in opioid analgesia:“from mouse to man”
Morinville et al. Regulation of δ-opioid receptor trafficking via μ-opioid receptor stimulation: evidence from μ-opioid receptor knock-out mice
Vanderah et al. Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin
Wang et al. Pronociceptive actions of dynorphin maintain chronic neuropathic pain
Tian et al. Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia
Nemirovsky et al. The antinociceptive effect of the combination of spinal morphine with systemic morphine or buprenorphine
Su et al. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception
Glass et al. Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy
Dogra et al. Biased agonism at kappa opioid receptors: Implication in pain and mood disorders
US8507440B2 (en) Protein kinase C peptides for use in withdrawal
Kotlinska et al. Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference
Sante et al. Place aversion induced by blockade of μ or activation of κ opioid receptors in the dorsal periaqueductal gray matter
Starowicz et al. Modulation of melanocortin-induced changes in spinal nociception by μ-opioid receptor agonist and antagonist in neuropathic rats
Chan et al. Molecular changes in opioid addiction: the role of adenylyl cyclase and cAMP/PKA system
Rizzi et al. Endogenous nociceptin signaling and stress-induced analgesia
Dogrul et al. Spinal L-type calcium channel blockade abolishes opioid-induced sensory hypersensitivity and antinociceptive tolerance
DiPirro et al. Placenta ingestion by rats enhances δ-and κ-opioid antinociception, but suppresses μ-opioid antinociception
Souter et al. Spinal interleukin-1βreduces inflammatory pain
Kutlu et al. Mu Opioid Modulation of Oxytocin Secretion in Late Pregnant and Parturient RatsInvolvement of Noradrenergic Neurotransmission
Lu et al. Differential opioid inhibition of C-and Aδ-fiber mediated thermonociception after stimulation of the nucleus raphe magnus
Levine et al. Intra-amygdalar injection of DAMGO: effects on c-Fos levels in brain sites associated with feeding behavior